Knoll Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $586K | Sell |
|
|||||
|
2022
Q2 | $4.37M | Hold |
|
|||||
|
2022
Q1 | $5.76M | Hold |
|
|||||
|
2021
Q4 | $3.6M | Hold |
|
|||||
|
2021
Q3 | $4.64M | Hold |
|
|||||
|
2021
Q2 | $5.92M | Hold |
|
|||||
|
2021
Q1 | $6.14M | Hold |
|
|||||
|
2020
Q4 | $8.53M | Buy |
|
|||||
|
2020
Q3 | $4.84M | Buy |
|
|||||
|
2020
Q2 | $5.06M | Buy |
|
|||||
|
2020
Q1 | $3.23M | Buy |
|
|||||
|
2019
Q4 | $5.22M | Hold |
|
|||||
|
2019
Q3 | $3.59M | Hold |
|
|||||
|
2019
Q2 | $3.71M | Buy |
|
|||||
|
2019
Q1 | $1.05M | Hold |
|
|||||
|
2018
Q4 | $764K | Hold |
|
|||||
|
2018
Q3 | $910K | Hold |
|
|||||
|
2018
Q2 | $918K | Hold |
|
|||||
|
2018
Q1 | $741K | Buy |
|